Hours after President Trump signed the 2018 Farm Bill into law, the FDA released a lengthy statement from its commissioner, Scott Gottlieb, M.D., updating its position on CBD products intended for human consumption. Flexing its muscle, the FDA points out that the Farm Bill “explicitly preserved the agency’s current authority to regulate products containing cannabis […]
2018 Farm Bill
New Law Removes Major Barrier for Hemp-based CBD Industry
By Rebecca Gwilt On December 12, 2018, Congress passed the 2018 Farm Bill (The “Agriculture Improvement Act of 2018” or the “Bill”), which includes provisions that exempt Cannabis plants with lower than 0.3% THC content (also called “Hemp”) from the Controlled Substances Act (CSA). Once signed into law, the Farm Bill effectively legalizes the production, […]
Will the FDA/DEA Epidiolex Rulings and the 2018 Farm Bill Change the Industry?
In late June 2018, the Food and Drug Administration announced approval for a new medication that could potentially change the way the world views cannabis. Epidiolex is a CBD-based oral solution that is prescribed to treat two forms of rare epilepsy. Patients who suffer from Dravet syndrome, as well as Lennox-Gastaut syndrome, may find that […]
